Firm Description

We shape the future - together
Our work is based on the firm conviction that the ability to provide legal services at the highest professional level requires more than just knowledge of the law. Only specialised legal expertise, combined with a profound knowledge of our clients’ industries, ensures both our clients’ and our own success. The life science law firm Ehlers, Ehlers und Partner has been established on this principle in 1987.

EEP stands for many years of experience in the area of life science law, and guarantees the best possible representation of our clients from the health care sector, with a focus on:

• European/German laws, rules, regulations and Industry Guidelines concerning Pharmaceuticals and Medical Devices
• German Health Care law
• Interactions with Healthcare professionals and Patient Organisations
• Medical law concerning Physicians treating Patients under within the German System of the Statutory Health Insurance
• Hospital law
• Pharmacy law
• Law concerning Biotechnics and Genetic Engineering
• GMP / GCP
• Corporate law / Mergers & Acquisitions
• Managed Care / Integrated Healthcare Services
• Public Policy Advisory

The legal environment for pharmaceuticals and medical devices are heavily regulated in Europe and Germany. In this industry, strategic decisions on how to best place a product on the market and decisions on how to best interact with healthcare professionals and patient organisations, as well as promotional activities are strongly influenced by legal provisions and industry guidelines. The same applies for pricing and reimbursement of pharmaceuticals and medical devices. In this regard, our life science group is highly experienced and gives targeted advice. Besides our legal expertise, we may provide our clients with additional support by the use of our extensive network to the respective decision makers.

We find solutions
Our concept of cutting edge legal advice compels us to conceive innovative ways to deal with complex problems particularly if the legal framework is tight and in times of tight budgets. We see litigation only as the ultima ratio.